Detalhe da pesquisa
1.
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.
Blood
; 140(12): 1378-1389, 2022 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35737911
2.
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Invest New Drugs
; 37(3): 548-558, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31028663
3.
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Br J Haematol
; 183(5): 819-822, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29193017
4.
Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162.
J Clin Med
; 12(22)2023 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38002810
5.
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma.
J Clin Med
; 11(23)2022 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36498736
6.
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial.
Lancet Haematol
; 8(1): e34-e44, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33357480
7.
Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Clin Lymphoma Myeloma Leuk
; 15(4): 208-13, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25468321
8.
A case of Philadelphia Positive Acute Lymphoblastic Leukaemia with three different phenotypic lineage, each one presenting the same BCR-ABL hybrid transcript.
Leuk Res
; 33(11): e175-7, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19476999